Oracle Corporation $ORCL Shares Sold by Legacy Private Trust Co.

Key Points

• Legacy Private Trust Co. cut its Oracle position by 56.9% in the third quarter, selling 4,229 shares and retaining 3,208 shares valued at approximately $440,000.
• Oracle reported quarterly revenue of $19.34 billion and adjusted earnings of $1.92 per share, exceeding analyst estimates; revenue increased 29.6% year over year. The company also declared a quarterly dividend of $0.50 per share, representing a 1.4% annual yield.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $251.72, although company insiders sold roughly $5.34 million of stock over the past three months.

Legacy Private Trust Co. lowered its position in Oracle Corporation (NYSE:ORCL - Free Report) by 56.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,208 shares of the enterprise software provider's stock after selling 4,229 shares during the period. Legacy Private Trust Co.'s holdings in Oracle were worth $440,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Rosenberg Matthew Hamilton increased its stake in shares of Oracle by 2.1% in the 3rd quarter. Rosenberg Matthew Hamilton now owns 4,350 shares of the enterprise software provider's stock valued at $597,000 after buying an additional 88 shares during the period. Ridgewood Investments LLC lifted its stake in shares of Oracle by 16.2% during the third quarter. Ridgewood Investments LLC now owns 12,841 shares of the enterprise software provider's stock valued at $1,763,000 after acquiring an additional 1,787 shares during the period. Polaris Financial Partners bought a new position in Oracle in the third quarter valued at about $103,000. CX Institutional boosted its holdings in Oracle by 490.1% in the third quarter. CX Institutional now owns 93,876 shares of the enterprise software provider's stock valued at $12,889,000 after acquiring an additional 77,968 shares during the last quarter. Finally, Doliver Advisors LP increased its position in Oracle by 10.7% in the third quarter. Doliver Advisors LP now owns 7,418 shares of the enterprise software provider's stock worth $1,018,000 after purchasing an additional 715 shares during the period. 42.44% of the stock is owned by institutional investors and hedge funds.

Oracle Trading Up 1.6%

ORCL opened at $144.73 on Wednesday. The firm's fifty day moving average is $145.44 and its two-hundred day moving average is $159.34. The firm has a market cap of $437.63 billion, a PE ratio of 22.69, a price-to-earnings-growth ratio of 1.01 and a beta of 1.78. Oracle Corporation has a twelve month low of $114.50 and a twelve month high of $322.54. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.17 and a current ratio of 1.17.

Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%.The firm had revenue of $19.34 billion for the quarter, compared to analyst estimates of $19.13 billion. During the same period in the previous year, the company posted $1.47 earnings per share. The company's revenue for the quarter was up 29.6% on a year-over-year basis. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Equities research analysts anticipate that Oracle Corporation will post 6.69 EPS for the current year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 23rd. Investors of record on Friday, October 9th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Friday, October 9th. Oracle's dividend payout ratio is presently 31.35%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. CLSA initiated coverage on shares of Oracle in a research note on Monday, July 20th. They issued a "hold" rating and a $145.00 target price on the stock. Royal Bank Of Canada cut their price objective on shares of Oracle from $190.00 to $165.00 and set a "sector perform" rating on the stock in a report on Friday, September 11th. TD Cowen reaffirmed a "buy" rating and set a $240.00 target price (down from $300.00) on shares of Oracle in a report on Wednesday, September 9th. Barclays upped their target price on shares of Oracle from $250.00 to $252.00 and gave the company an "overweight" rating in a research report on Friday, September 11th. Finally, UBS Group increased their price target on Oracle from $245.00 to $250.00 and gave the company a "buy" rating in a research note on Friday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, thirty-six have assigned a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $251.72.

Insiders Place Their Bets

In related news, EVP Maria Smith sold 2,631 shares of the business's stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $151.70, for a total value of $399,122.70. Following the sale, the executive vice president directly owned 64,357 shares of the company's stock, valued at approximately $9,762,956.90. The trade was a 3.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Michael D. Sicilia sold 22,562 shares of the company's stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $151.59, for a total transaction of $3,420,173.58. Following the completion of the transaction, the chief executive officer directly owned 182,929 shares of the company's stock, valued at approximately $27,730,207.11. The trade was a 10.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 36,075 shares of company stock worth $5,342,123. Company insiders own 38.40% of the company's stock.

More Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle’s AI infrastructure story continues to attract attention. A reported deal involving Tencent and approximately 100,000 AI chips is being viewed as evidence of strong demand for rented computing capacity and could support future cloud growth. 100,000 Reasons to Buy Oracle Stock
• Positive Sentiment: Director Stephen Rusckowski purchased nearly $3.5 million of Oracle stock, providing an insider vote of confidence while the shares trade well below their 52-week high. Monster insider trading alert for Oracle stock
• Positive Sentiment: Analyst commentary remains bullish on Oracle’s roughly $664 billion backlog, arguing that future contract conversions could eventually offset current investment and cash-flow pressure. Oracle has also been highlighted as an AI stock with additional healthcare, agentic-AI and enterprise-cloud initiatives. Oracle at $140: Buying Negative FCF Never Looked So Good
• Positive Sentiment: Oracle committed $10 million to support the Nashville Symphony, strengthening its local corporate presence and helping restore the organization’s 2026-27 season. The announcement was a positive headline but is not expected to materially affect earnings. Oracle Trending After $10 Million Investment
• Neutral Sentiment: Commentary on Oracle’s relationship with OpenAI and its AI partnerships suggests potentially meaningful long-term demand, but provides limited new financial detail for near-term valuation. Oracle: OpenAI Is Back, But Wall Street Is Sleeping
• Negative Sentiment: A Texas attorney general disclosure said a 2025 breach at Oracle’s healthcare unit compromised data belonging to nearly 20 million people, including sensitive medical and personal information. Potential regulatory, legal and reputational costs represent a significant overhang. Oracle 2025 Health Breach Compromised Data of 20 Million People
• Negative Sentiment: Oracle’s aggressive AI data-center expansion is consuming substantial cash and increasing debt-related concerns. Michael Burry warned that the backlog may conceal financing and customer-credit risks, while reports of possible December voluntary layoffs underscore efforts to control costs. Michael Burry Raises Red Flag on Oracle’s Backlog and AI Spending

Oracle Profile

Oracle Corporation NYSE: ORCL is a global technology company that develops enterprise software, cloud services and related hardware. Its offerings help businesses manage databases, applications, data, infrastructure and other core information-technology operations.

The company is best known for its Oracle Database, along with cloud-based infrastructure and platform services. Oracle also provides enterprise applications for functions such as finance, human resources, supply-chain management, customer experience and industry-specific operations.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.